Table of Contents

1 Aliskiren Market Overview

• 1.1 Product Overview and Scope of Aliskiren
• 1.2 Classification of Aliskiren by Types
  • 1.2.1 Global Aliskiren Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Aliskiren Revenue Market Share by Types in 2018
  • 1.2.3 150 mg Tablet
  • 1.2.4 300 mg Tablet
• 1.3 Global Aliskiren Market by Application
  • 1.3.1 Global Aliskiren Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospital
  • 1.3.3 Drug store
• 1.4 Global Aliskiren Market by Regions
  • 1.4.1 Global Aliskiren Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Aliskiren Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Aliskiren Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Aliskiren Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Aliskiren Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Aliskiren Status and Prospect (2014-2024)
• 1.5 Global Market Size of Aliskiren (2014-2024)

2 Manufacturers Profiles

• 2.1 Noden Pharma
  • 2.1.1 Business Overview
  • 2.1.2 Aliskiren Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Noden Pharma Aliskiren Revenue, Gross Margin and Market Share (2017-2018)

3 Global Aliskiren Market Competition, by Players

• 3.1 Global Aliskiren Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Aliskiren Players Market Share
  • 3.2.2 Top 10 Aliskiren Players Market Share
• 3.3 Market Competition Trend

4 Global Aliskiren Market Size by Regions

• 4.1 Global Aliskiren Revenue and Market Share by Regions
• 4.2 North America Aliskiren Revenue and Growth Rate (2014-2019)
• 4.3 Europe Aliskiren Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Aliskiren Revenue and Growth Rate (2014-2019)
• 4.5 South America Aliskiren Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Aliskiren Revenue and Growth Rate (2014-2019)

5 North America Aliskiren Revenue by Countries

• 5.1 North America Aliskiren Revenue by Countries (2014-2019)
• 5.2 USA Aliskiren Revenue and Growth Rate (2014-2019)
• 5.3 Canada Aliskiren Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Aliskiren Revenue and Growth Rate (2014-2019)

6 Europe Aliskiren Revenue by Countries

• 6.1 Europe Aliskiren Revenue by Countries (2014-2019)
• 6.2 Germany Aliskiren Revenue and Growth Rate (2014-2019)
• 6.3 UK Aliskiren Revenue and Growth Rate (2014-2019)
• 6.4 France Aliskiren Revenue and Growth Rate (2014-2019)
• 6.5 Russia Aliskiren Revenue and Growth Rate (2014-2019)
• 6.6 Italy Aliskiren Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Aliskiren Revenue by Countries

• 7.1 Asia-Pacific Aliskiren Revenue by Countries (2014-2019)
• 7.2 China Aliskiren Revenue and Growth Rate (2014-2019)
• 7.3 Japan Aliskiren Revenue and Growth Rate (2014-2019)
• 7.4 Korea Aliskiren Revenue and Growth Rate (2014-2019)
• 7.5 India Aliskiren Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Aliskiren Revenue and Growth Rate (2014-2019)

8 South America Aliskiren Revenue by Countries

• 8.1 South America Aliskiren Revenue by Countries (2014-2019)
• 8.2 Brazil Aliskiren Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Aliskiren Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Aliskiren Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Aliskiren by Countries

• 9.1 Middle East and Africa Aliskiren Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Aliskiren Revenue and Growth Rate (2014-2019)
• 9.3 UAE Aliskiren Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Aliskiren Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Aliskiren Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Aliskiren Revenue and Growth Rate (2014-2019)

10 Global Aliskiren Market Segment by Type

• 10.1 Global Aliskiren Revenue and Market Share by Type (2014-2019)
• 10.2 Global Aliskiren Market Forecast by Type (2019-2024)
• 10.3 150 mg Tablet Revenue Growth Rate (2014-2024)
• 10.4 300 mg Tablet Revenue Growth Rate (2014-2024)

11 Global Aliskiren Market Segment by Application

• 11.1 Global Aliskiren Revenue Market Share by Application (2014-2019)
• 11.2 Aliskiren Market Forecast by Application (2019-2024)
• 11.3 Hospital Revenue Growth (2014-2019)
• 11.4 Drug store Revenue Growth (2014-2019)

12 Global Aliskiren Market Size Forecast (2019-2024)

• 12.1 Global Aliskiren Market Size Forecast (2019-2024)
• 12.2 Global Aliskiren Market Forecast by Regions (2019-2024)
• 12.3 North America Aliskiren Revenue Market Forecast (2019-2024)
• 12.4 Europe Aliskiren Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Aliskiren Revenue Market Forecast (2019-2024)
• 12.6 South America Aliskiren Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Aliskiren Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology

Aliskiren (trade names Tekturna and Rasilez) is the first in a class of drugs called direct renin inhibitors. It is used for essential (primary) hypertension.

Scope of the Report:
The global Aliskiren market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Aliskiren.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Aliskiren market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Aliskiren market by product type and applications/end industries.

Market Segment by Companies, this report covers
Noden Pharma

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
150 mg Tablet
300 mg Tablet

Market Segment by Applications, can be divided into
Hospital
Drug store